Furthermore, the authors indicated that YPFS exerted anti-inflammatory effects in COPD rats by inhibiting the expression of inflammatory cytokines, potentially through the suppression of the TGF-β1/Smad2 signaling pathway [85]. Here, SMAD2 is linked to chronic obstructive pulmonary disease.